___

• 1. Gill K, Kumar S, Xess I, Dey S. Novel synthetic anti-fungal tripeptide effective against Candida krusei. Indian J Med Microbiol 2015; 33 (1):110-116. 2. Jayachandran AL, Katragadda R, Thyagarajan R, et al. Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinic mycological Association and Antifungal Susceptibility Pattern. Can J Infect Dis Med Microbiol 2016; 8758461. http://dx.doi.org/10.1155/2016/8758461 3. Giri S, Kindo AJ. Evaluation of Antifungal susceptibility testing in Candida isolates by Candifast and disk-diffusion method. Indian J Pathol Microbiol 2014; 57:595-7. 4.Agarwal S, Manchanda V, Verma N et al. Yeast identification in routine clinical microbiology laboratory and its clinical relevance. Indian J Med Microbiol.2011; 29 (2): 172-177. 5. Clinical and Laboratory Standards Institute. Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline, 2nd ed., M44-A2.Clinical and Laboratory Standards Institute, Wayne, PA.USA 2008. 6 .Clinical and Laboratory Standards Institute (CLSI), “Reference method for broth dilution antifungal susceptibility testing of yeasts.3rd ed., Document M27-A3, Wayne, Pa, USA, 2008. 7. Tankhiwale S, Gajbhiye S, Powar R. fluconazole susceptibility testing of Candida species by disc diffusion and agar dilution method. J Evolut Med Dent Sci 2012; 1(4): 527-531. 8 .Ying Y, Zhang J, Huang SB et al. Fluconazole susceptibility of 3,056 clinical isolates of Candida species from 2005 to 2009 in a tertiary-care hospital. Indian J Med Microbiol 2015; 33(3):413-415. 9. Pfaller MA, Diekema DJ, Gibbs DL et al. Global Antifungal Surveillance Group Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: A 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 2010; 48 (4):1366-77. 10. Gandhi TN, Patel MG, Jain MR. Antifungal Susceptibility of Candida against Six Antifungal Drugs by Disk Diffusion Method Isolated from Vulvovaginal Candidiasis. Int J Cur Res Rev 2015; 7 (11): 20-25. 11. Kumar D, Bhattacharyya S, Gupta P, et al. Comparative Analysis of Disc Diffusion and E-test with Broth Micro-dilution for Susceptibility Testing of Clinical Candida Isolates Against Amphotericin B, Fluconazole, Voriconazole and Caspofungin. J Clin Diag Res 2015; 9 (11): 1-4. 12.Jayalakshmi L, Ratna Kumari G, Samson SH. Isolation, Speciation and Antifungal Susceptibility Testing of Candida from Clinical Specimens at a Tertiary Care Hospital. Sch J App Med Sci, 2014; 2(6E):3193-198. 13.Adhikary R, Joshi S. Species distribution and antifungal susceptibility of candidemia at a multi super specialty centre in Southern India. Indian J Med Microbiol 2011; 29(3):309‑311. 14.Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39(1): 1-8. 15. Kothari A, Sagar V. Epidemiology of candida blood stream infections in a tertiary care institute in India. Indian J Med Microbiol 2008; 27(2):171‑172. 16. Matar MJ, Zeichner LO, Paetznick VL, et al. Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole. Antimicrob Agents Chemother. 2003; 47(5): 1647-1651. 17. Negri M, Henrique’s M, Svidzinski TI, et al. Correlation between E test, disk diffusion, and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization. J Clin Lab Anal 2009; 23(5): 324-330.